Vimta Labs Limited Stock NSE India S.E.

Equities

VIMTALABS

INE579C01029

Biotechnology & Medical Research

Delayed NSE India S.E. 06:24:40 2024-04-29 EDT 5-day change 1st Jan Change
543.4 INR +0.18% Intraday chart for Vimta Labs Limited +17.01% +34.64%

Financials

Sales 2022 2.79B 33.42M 45.62M Sales 2023 3.19B 38.25M 52.21M Capitalization 6.95B 83.36M 114M
Net income 2022 413M 4.95M 6.76M Net income 2023 482M 5.78M 7.89M EV / Sales 2022 2.53 x
Net Debt 2022 85.41M 1.02M 1.4M Net cash position 2023 242M 2.9M 3.95M EV / Sales 2023 2.1 x
P/E ratio 2022
17.2 x
P/E ratio 2023
14.7 x
Employees 1,368
Yield 2022
0.63%
Yield 2023
0.64%
Free-Float 30.69%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.18%
1 week+17.01%
Current month+22.42%
1 month+19.55%
3 months+27.49%
6 months+20.62%
Current year+34.64%
More quotes
1 week
466.20
Extreme 466.2
609.00
1 month
442.20
Extreme 442.2
609.00
Current year
404.00
Extreme 404
609.00
1 year
365.80
Extreme 365.8
623.15
3 years
215.50
Extreme 215.5
623.15
5 years
51.50
Extreme 51.5
623.15
10 years
51.50
Extreme 51.5
623.15
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 94-12-31
Founder 75 83-12-31
Director of Finance/CFO - 21-02-21
Members of the board TitleAgeSince
Founder 75 83-12-31
Chief Operating Officer 72 83-12-31
Chief Executive Officer 49 94-12-31
More insiders
Date Price Change Volume
24-04-29 543.4 +0.18% 83 437
24-04-26 542.4 -3.21% 146,994
24-04-25 560.4 +10.05% 693,920
24-04-24 509.2 +6.50% 110,780
24-04-23 478.1 +2.96% 13,588

Delayed Quote NSE India S.E., April 29, 2024 at 06:24 am

More quotes
Vimta Labs Limited is engaged in the business of contract research and testing organization. The Company is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include Drug discovery, development, and drug life cycle management support services; Preclinical research and testing services for medical device companies; Contract research and testing for agrochemical and specialty chemical companies; and Food testing and analytical development services to support manufacturers, processors, farmers, and retailers; Clinical diagnostics services to patients, clinicians, and hospitals, and environmental regulatory services such as impact assessments and post project monitoring, to various industries, such as power and infrastructure.
More about the company